The Latin American PV device market will see moderate growth through 2025, driven by endovascular procedure volume growth and rising PVD diagnosis rates, although cost constraints in the publicly funded health care system continue to hinder penetration of premium priced products such as DCBs and DES.

This Medtech 360 Report provides high-level market metrics for PV devices in Latin America, including country-level data for major countries and aggregate data for the rest of Latin America, across a 10-year period.

Table of contents

  • Peripheral Vascular Devices - Market Insights - Latin America (Supplemental)

Author(s): Pankhil Gandhi, PharmD

Pankhil Gandhi is a research associate within the Cardiovascular Medtech Insights team at Decision Resources Group, specializing in transcatheter embolization and occlusion devices and deep venous disease treatment devices markets. Pankhil holds a Doctor of Pharmacy degree from the Babasaheb Ambedkar Marathwada University, Aurangabad.


Related Reports

Peripheral Vascular Devices - Market Insights - Europe Part 2

The European market for PV devices is a dynamic market that will grow through 2029, driven by the availability of new products backed by clinical data. Howe...

View Details

Peripheral Vascular Devices - Market Insights - Japan

The Japanese PV device market will see modest growth through 2029, driven primarily by the expanding ...

View Details

Peripheral Vascular Devices - Market Insights - United States

The US market for PV devices is an evolving market, where a large undiagnosed patient population and innovative product launches will allow for

View Details

Peripheral Vascular Devices - Market Insights - Asia Pacific

The Asia Pacific market for PV devices will grow modestly through 2029, fueled by the growing PAD populatio...

View Details